top of page
Glossary Term
< Return to Main Navigation

High-Risk Devices

Definition

High-risk devices are medical devices that present a significant potential risk to patient safety if they fail to perform as intended. These devices typically include those that are life-supporting, life-sustaining, or implanted into the body. High-risk devices are subject to the most stringent regulatory controls, including rigorous clinical evaluation, premarket approval (PMA), and post-market surveillance.

Relevance to the MedTech Industry

High-risk devices are designed to address critical healthcare needs, such as supporting vital functions, diagnosing life-threatening conditions, or providing therapeutic interventions. Their development and regulation are vital to ensuring patient safety while delivering innovative solutions for complex medical challenges.

Additional Information & Related Terms

Examples of High-Risk Devices

  • Implantable Cardioverter Defibrillators (ICDs): Devices that detect and treat life-threatening arrhythmias.

  • Artificial Heart Valves: Replace malfunctioning heart valves to maintain proper blood flow.

  • Deep Brain Stimulators: Implantable devices used to treat neurological conditions like Parkinson’s disease.

  • Spinal Cord Stimulators: Devices for managing chronic pain by delivering electrical impulses to the spinal cord.

Key Regulatory Requirements

  1. Premarket Approval (PMA): Required for high-risk devices in the U.S., demanding clinical data and a detailed risk-benefit analysis.

  2. EU MDR Class III: High-risk devices in the EU must meet stringent requirements under the Medical Device Regulation (MDR), including clinical investigation and notified body review.

  3. Risk Management: Compliance with ISO 14971 to identify, evaluate, and mitigate risks throughout the device lifecycle.

  4. Post-Market Surveillance (PMS): Ongoing monitoring of device performance and adverse event reporting.

Related Terms

  • Class III Medical Devices (FDA): High-risk devices as categorized by the FDA.

  • Post-Market Surveillance (PMS): Essential for monitoring the safety and performance of high-risk devices.

  • Premarket Approval (PMA): The FDA’s most rigorous regulatory pathway for high-risk devices.

  • ISO 14971: A standard for risk management critical in the development of high-risk devices.

bottom of page